Pathogenesis of Nasal Polyposis.docx
- 文档编号:10428641
- 上传时间:2023-02-11
- 格式:DOCX
- 页数:68
- 大小:249.47KB
Pathogenesis of Nasal Polyposis.docx
《Pathogenesis of Nasal Polyposis.docx》由会员分享,可在线阅读,更多相关《Pathogenesis of Nasal Polyposis.docx(68页珍藏版)》请在冰豆网上搜索。
PathogenesisofNasalPolyposis
PathogenesisofNasalPolyposis
KathrynE.Hulse,PhD1*,WhitneyW.Stevens,MD,PhD1,BruceK.Tan,MD2,RobertP.Schleimer,PhD1,2
1DivisionofAllergy-Immunology,DepartmentofMedicine,NorthwesternUniversityFeinbergSchoolofMedicine,Chicago,ILUSA;2DepartmentofOtolaryngology,NorthwesternUniversityFeinbergSchoolofMedicine,Chicago,IL,USA
*Correspondingauthor:
Dr.KathrynE.Hulse,DivisionofAllergy-Immunology,NorthwesternUniversityFeinbergSchoolofMedicine,240E.HuronSt.,McGawRmM-302,Chicago,IL,60611,USA.
Tel.:
312-503-2854
Fax:
312-503-0078
Email:
k-hulse@northwestern.edu
Funding:
NIHR37HL068546,R01HL078860,R01AI072570,P01106683-01,K12
HD055884,T32AI083216-04,K23DC012067andtheErnestS.BazleyTrust
Abstract
Chronicrhinosinusitiswithnasalpolyps(CRSwNP)isacomplexinflammatoryconditionthataffectsalargeproportionofthepopulationworldwideandisassociatedwithhighcostofmanagementandsignificantmorbidity.Yet,thereisalackofpopulation-basedepidemiologicstudiesusingcurrent
definitionsofCRSwNP,andthemechanismsthatdrivepathogenesisinthisdiseaseremainunclear.
Inthisreview,wesummarizethecurrentevidencefortheplethoraoffactorsthatlikelycontributetoCRSwNPpathogenesis.Defectsintheinnatefunctionoftheairwayepithelialbarrier,includingdiminishedexpressionofantimicrobialproductsandlossofbarrierintegrity,combinedwithcolonizationbyfungiandbacterialikelyplayacriticalroleinthedevelopmentofchronicinflammationinCRSwNP.Thischronicinflammationischaracterizedbyelevatedexpressionofmanykeyinflammatorycytokinesandchemokines,includingIL-5,thymicstromallymphopoietin,andCCL11,thathelptoinitiateandperpetuatethischronicinflammatoryresponse.Together,thesefactorslikelycombinetodrivetheinfluxofavarietyofimmunecells,includingeosinophils,mastcells,type2innatelymphoidcellsandlymphocytes,whichparticipateinthechronicinflammatoryresponsewithinthenasalpolyps.Importantlyhowever,futurestudiesareneededtodemonstrate
thenecessityandsufficiencyofthesepotentialdriversofdiseaseinCRSwNP.Inadditiontothe
developmentofnewtoolsandmodelstoaidmechanisticstudies,thefieldofCRSwNPresearch
alsoneedsthetypeofrobustepidemiologicdatathathasservedtheasthmacommunitysowell.Giventhehighprevalence,costs,andmorbidity,thereisagreatneedforcontinuedresearchintoCRSthatcouldfacilitatethedevelopmentofnoveltherapeuticstrategiestoimprovetreatmentforpatientsthatsufferfromthisdisease.
Introduction
Thepurposeofthisreviewistosummarizethecurrentstateofknowledgeregardingthepathogenesisofnasalpolyposis.Inthisreview,wefocusonchronicrhinosinusitiswithnasalpolyps(CRSwNP),ratherthanotherconditionsassociatedwithnasalpolypformationsuchasantrochoanalpolyps,cysticfibrosisorallergicfungalsinusitis,duetothesignificantlyhigherprevalenceandassociatedcostsofmanagementofCRSwNP.
EpidemiologyofCRSwNP
Chronicrhinosinusitis(CRS)ischaracterizedbythepresenceoffourcardinalsymptoms:
nasalobstruction,drainage,smelllossandfacialpainorpressure,whichlastforatleastthreemonths.InsomepatientswithCRS,exuberanthyperplasticinflammatorygrowthofnasalpolypsintothenasalairwayisobserved[1-3].Thereisapaucityoflargepopulation-basedepidemiologicstudiesconductedusingcurrentdefinitionsofCRS,andfewerstudiesyetthatspecificallydelineatetheproportionofpatientswhohaveCRSwNP.Tworecentpopulation-basedstudiesconductedinEuropeandSouthKoreathatusedbothsymptomhistoriesandendoscopicexamsestimatedtheprevalenceofCRSinthegeneralpopulationat10.9%and7.0%ofadults,respectively,buttheydidnotdefinetheproportionofCRSpatientswithnasalpolyps[4,5].StudiesthathavespecificallyexaminedCRSwNPsuggestitspopulationprevalenceisaround2.7%ofadultsinasinglemunicipalityofSweden[6],anditsincidencehasbeenestimatedat0.63or0.83patientsperthousandperyearbasedonstudiesinaDanishcountyorinCentralPennsylvania,respectively[7,8].Basedonthesestudies,thereisapredominanceofmenwithCRSwNP,withamaletofemaleratiovaryingfrom1.3-2.2,andapeakincidencebetweentheagesof45and65.WhileCRSwNPisthelesscommonformofCRS,wehavenotedthattheproportionofCRSpatientswithnasalpolypsissubstantiallyhigherinsurgicalcohortsoftertiarycarepatientswhohadfailedmedicalmanagement(~50%)whencomparedwithincidentcaseswheretheproportionofCRSpatientswithnasalpolypsmaybeaslowas7%[9,10].Together,thesestudiessuggestthatcomparedtoCRSsNP,CRSwNPmaypersistforalongerduration,berelativelyrecalcitranttomedicalmanagement,morefrequentlyleadtosurgicalmanagementand/orrequiremoresurgeriestoaddress.WhiletotalCRSmanagementcostsareestimatedtobeover$8billionannuallyintheUnitedStates[11],therearenostudies,toourknowledge,thathaveprovidedestimatesofdirectcostsassociatedwithCRSwNPmanagement.Inadditiontodirectcostsofmanagement,studieshaveshownthatCRSpatientsseeninatertiarycaresettingsufferasignificantlyimpaired
qualityoflifecomparabletocongestiveheartfailureandchronicobstructivepulmonarydisease[12].AlthoughourunpublisheddatasuggeststhatpatientswithCRSwNPmayhavemarginallylessimpairmentofqualityoflifethanthosewithoutpolyps,otherstudieshaveshownthatCRSwNPpatientsaremorebotheredbyrhinorrheaandsmell/tastedisturbancesandlessbotheredbyfacialpain[13].Certainly,itiswellestablishedthatpatientswithCRSwNPdohavemorefrequentimpairmentfromco-morbidconditionssuchasasthmaandatopicmulti-sensitizationthanthegeneralpopulation[8,10].WhileepidemiologicstudyofCRSwNPisinitsinfancy,sorelyneededstudiesinprimarycarepopulationswillhopefullyyieldimportantinformationregardingtheenvironmentaloroccupationalfactorsthatdrivediseaseformationandpersistence.
Aspirin-ExacerbatedRespiratoryDisease(AERD)
ItisimportanttoemphasizethatthereisaspecificsubsetofpatientswithCRSwNPwithseverediseasethatsuffersfromaspirin-exacerbatedrespiratorydisease(AERD),otherwiseknownasSamter’striad.Thesepatientshaveasthma,CRSwNP,anddevelopexacerbatedairwayresponsesfollowingingestionofmedicationsthatinhibitthecyclooxygenase(COX)1enzyme.AlthoughAERDpatientsoftenpresentwiththemostseveremanifestationsofbothasthmaandnasalpolyposis,thisdiseaseislesscommonthaneitherCRSwNPorasthmaandiscurrentlyunderstudied.TheprevalenceofAERDhasbeenestimatedtobeasmuchas0.6-2.5%inthegeneralpopulation,withhigherprevalenceamongasthmaticandCRSwNPpatients[14-16].However,thepublishedworkonAERDhasbeenhamperedbydifferingdefinitionsofAERDusedbydifferentgroupsofinvestigators.Forexample,whilesomerequiredocumentedairwayreactionstoCOX-1inhibitorsalongwithasthmaandCRSwNPforAERDdiagnosis,othersdonotspecifythetypeofreactiontoCOX-1inhibitorsintheirpatients,andsomestudiesdonotrequirepatientstohaveCRSwNPfortheirdefinitionofAERD.Thus,thepopulationprevalenceestimatesabovemaynottrulyreflectthepopulationofpatientswhohavethetriadof
asthma,CRSwNPandairwayresponsestoCOX-1inhibitors.Thus,itisunclearwhetherAERDrepresentsthesevereendoftheCRSwNPdiseasespectrum,orifitisadistinctclinicalentity.Although,itisclearthat,AERDpatientsuniquelyrespondtoaspirindesensitizationtherapy[17],andhavehigherbaselinelevelsofurinaryleukotrieneE4[18],suggestingthatdistinctmolecularmechanisms,suchasdysregulationofarachidonicacidmetabolism,drivethisuniquedisease[19-21].ThepathogenesisofAERDisnotdiscussedfurtherinthisreview.
AllergicFungalRhinosinusitis(AFRS)
Patientswithallergicfungalrhinosinusitis(AFRS)representanotherdistinctsubsetofCRSwNP.ThesepatientsareoftenatopicandhavehighlyelevatedserumIgElevels[22],andtheycanbedistinguishedfromotherCRSwNPpatientsbythepresenceofeosinophilicmucinwithoutfungalinvasionofthemucosa,mucuswithpositivefungalstaining,andoften,bonyerosion[23].Interestingly,theestimatedprevalenceofAFRSvarieswidelyacrossdifferentgeographicregionsoftheUnitedStates,suchthatAFRShasbeenestimatedtoaccountfor
>20%ofallpatientsundergoingendoscopicsinusproceduresinsouthernareasofthecountry,suchasMemphis,butonly0-4%ofthesesamepatientsinnorthernregionsofthecountry[24].LikeAERD,itisnotclearwhetherAFRSisdrivenbydistinctpathogenicmechanismsfromCRSwNP,orissimplypartoftheCRSwNPdiseasespectrum[23],andwewillnotdiscussthepathogenesisofAFRSfurtherinthisreview.
EasternVersusWesternPresentationsofCRSwNP
CRSwNPinWesternpopulationsisoftencharacterizedbytype2inflammation,withelevatedlevelsoftype2cytokines,suchasIL-5andIL-13,alongwitheosinophilia.However,thereisaccumulatingevidencefromAsiancountries,especiallyinChina,KoreaandJapan,thatCRSwNPintheirpopulationsmaybecharacterizedbyamixedtype1ortype3inflammation,withamoreneutrophilicinflammationthanobservedinNPinpatientsfromtheUSorEurope
[25].Themechanismsthatdrivethesedifferentphenotypesareunclearatthistime.Interestingly,recentworkfromourgroupfoundthattissuefromNPfromsecondgenerationAsianpatientsborninandlivingintheUSwereconsiderablylesseosinophilicthanNPtissuefromCaucasian,Afric
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- Pathogenesis of Nasal Polyposis
![提示](https://static.bdocx.com/images/bang_tan.gif)